Logo of BIofidus AG

Forced Degradation Studies

Forced degradation studies of biologics are a set of experiments designed to evaluate the stability of the active pharmaceutical ingredient (API) and drug product under extreme conditions. These studies involve exposing the biologic to a range of physical, chemical, and environmental stress conditions such as temperature, pH, oxidative stress, and photolytic degradation, to mimic an accelerated, environmental stability of the drug.

The studies embrace complex and comprehensive analytical pipelines to identify and characterize occurring degradation products (impurities) that may arise during the product’s lifecycle and how they affect the quality, safety, and efficacy of the drug. The results of these studies will improve the design and selection of appropriate production, formulation, packaging, and storage conditions to ensure the stability and quality of your drug product.

Our vast experience and deep knowledge in assessing the impact of degradants allows us to predict if your product will meet consistently approved acceptance criteria for product stability. Biofidus offers a holistic and state-of-the-art forced degradation assessment service according to the ICH Q1 guidelines, to accelerate the approval of your biologic or biosimilar. In accordance with your needs, we adapt and, if required, qualify (according to ICH guidelines) our platform methods tailored to your drug substance (DS), its individual formulation matrix and your distinct analytical question.

Get in contact with us to quickly find the optimal setup for your analytical challenge and to speak directly from expert to expert.

Our capabilities

bioanalytical services

draft of chemical sctructure of a fictive carbon hydrate backbone

PROTEIN SEQUENCE ANALYSIS

draft of 8 rectangularly ordered capsules with one capsule shown upside down
IMPURITY ANALYSIS
draft of chemical sctructure of a fictive carbon hydrate backbone with two phenyl groups
AMINO ACID (AA) MODIFICATIONS
draft of two aggregated igG antibodies generated by Biofidus AG
AGGREGATION ANALYSIS
draft of two igG antibodies one with a circled plus and one with a circled minus to symbolise charge heterogeneities generated by Biofidus AG
CHARGE HETEROGENITY
rectangularly ordered black circles with a few filled and empty ones
BIOACTIVITY STUDIES
twirled black line
HIGHER ORDER STRUCTURE CHARACTERIZATION
draft of igG Antibody with glycosylation pattern at the FC region generated by Biofidus AG
GLYCOSYLATION ANALYSIS
draft of two test tubes connected via a tube to symbolise CE analysis generated by BIofidus
CE ANALYSIS
draft of test tubes in a rack generated by Biofidus AG
CELL BASED ASSAYS
draft of typical SPR binding curves in an xy diagram generated by Biofidus AG
SPR ANALYSIS

Tell us about your project

We‘ll advice you to define your assay needs

By sending the contact form you agree to our privacy policy.
*By submitting this form, you are consenting to receive emails from: Biofidus AG. You can revoke your consent at any time by using the unsubscribe link, found at the bottom of every email. Please see our privacy policy.

Technologies used

For all inquiries related to our froced degradation services reach out directly to Our expert Dr. Anja Doebbe.

Phone: +49(0)521 89 739 064 Mail: Anja.Doebbe@Biofidus.de
WordPress Cookie Plugin von Real Cookie Banner